Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices
The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanism...
Saved in:
Published in | Frontiers in pharmacology Vol. 14; p. 1127388 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
05.05.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an
ex-vivo
platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. |
---|---|
AbstractList | The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an
platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity.The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1-10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19 patients. HCQ and AZM have been associated with QT interval prolongation and drug-induced arrhythmias, however other cardiotoxicity mechanisms remain largely unexplored. Our group has pioneered the living heart slice preparation, an ex-vivo platform that maintains native cardiac tissue architecture and physiological electrical and contractile properties. Here, we evaluated the cardiotoxic effect of HCQ and AZM applied alone or in combination on cardiac contractility by measuring contractile force and contraction kinetics in heart slices prepared from porcine hearts. Our results show that clinically relevant concentrations of HCQ monotherapy (1–10 µM) reduced contractile force and contraction kinetics in porcine slices in a dose-dependent manner. However, AZM monotherapy decreased contractile force and contraction kinetics only at higher concentrations (30 µM). Combination of HCQ and AZM induced a dose-dependent effect similar to HCQ alone. Furthermore, pre-treating porcine heart slices with the L-type calcium channel agonist Bay K8644 prevented the effect of both drugs, while administration of Bay K8644 after drugs interventions largely reversed the effects, suggesting a mechanism involving inhibition of L-type calcium channels. These findings indicate that HCQ and AZM alter cardiac function beyond QT prolongation with significant contractile dysfunction in intact cardiac tissue. Our porcine heart slices provide a powerful platform to investigate mechanisms of drug cardiotoxicity. |
Author | Wu, Qin Johnson, Robert D. Camelliti, Patrizia Thompson, Georgina H. Ross, Abigail J. Ipek, Tugce Wu, Changhao |
AuthorAffiliation | 1 School of Medicine , Jiangsu Vocational College of Medicine , Yancheng , China 2 School of Biosciences and Medicine , University of Surrey , Guildford , United Kingdom |
AuthorAffiliation_xml | – name: 2 School of Biosciences and Medicine , University of Surrey , Guildford , United Kingdom – name: 1 School of Medicine , Jiangsu Vocational College of Medicine , Yancheng , China |
Author_xml | – sequence: 1 givenname: Qin surname: Wu fullname: Wu, Qin – sequence: 2 givenname: Abigail J. surname: Ross fullname: Ross, Abigail J. – sequence: 3 givenname: Tugce surname: Ipek fullname: Ipek, Tugce – sequence: 4 givenname: Georgina H. surname: Thompson fullname: Thompson, Georgina H. – sequence: 5 givenname: Robert D. surname: Johnson fullname: Johnson, Robert D. – sequence: 6 givenname: Changhao surname: Wu fullname: Wu, Changhao – sequence: 7 givenname: Patrizia surname: Camelliti fullname: Camelliti, Patrizia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37214466$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uktv1DAQtlARfdA_wAHlyGUXPxLHPiFUAa1UiUtPXKyJM9m48saL7a3Y_nqc3W3VcsAXW_b38Mx85-RkChMS8oHRpRBKfx42I8Qlp1wsGeOtUOoNOWNSioVWjJ-8OJ-Sy5TuaVlCayHrd-RUtJzVtZRn5Nf1ro_hz86OPsTwe-smrGDqK3h0eYxhvbNuqsBnjFUesbJhyhFsdt7lXRWGyrsHN62qTYh2po4IMVfJO4vpPXk7gE94edwvyN33b3dX14vbnz9urr7eLmwtdV4MIBl2HDsLLQfW9qUWizWzvRW0k41kgwDVWy2x6bmgOHRcN2gBlcaGiQtyc5DtA9ybTXRriDsTwJn9RYgrU_7krEfTyR5KC2pQqq6LVadlXXQ0Q9q1FHXR-nLQ2my7NfYW52r9K9HXL5MbzSo8GEaZlqJRReHTUWHuJqZs1i5Z9B4mDNtkuGKKNi1tmwL9-NLs2eVpOAXADwAbQ0oRh2cIo2YOgdmHwMwhMMcQFJL6h2Rdhuz2g3P-f9S_BBC7gw |
CitedBy_id | crossref_primary_10_3389_fcvm_2023_1244630 |
Cites_doi | 10.1089/ten.tec.2022.0053 10.1161/CIRCRESAHA.117.310230 10.1007/s12012-014-9289-4 10.1016/j.isci.2021.103509 10.1093/eurheartj/ehz779 10.1038/s41591-020-0888-2 10.1016/j.ajem.2019.158387 10.1038/s41422-020-0282-0 10.1093/cid/ciaa691 10.3390/antibiotics8030110 10.1159/000257528 10.1093/toxsci/kfaa194 10.5483/BMBRep.2020.53.10.165 10.1016/0014-2999(81)90458-1 10.1007/s10557-018-06847-9 10.3389/fphys.2022.839140 10.1016/j.yjmcc.2020.12.014 10.1016/s1043661802002384 10.1111/bph.15101 10.3390/ph15020220 10.1016/j.xcrm.2021.100216 10.1161/CIRCEP.115.003560 10.2217/fca.09.32 10.3389/fphys.2019.00755 10.1007/BF00261499 10.1111/j.1476-5381.2011.01775.x 10.1111/cts.13011 10.1183/09031936.00095809 10.1016/S1473-3099(07)70187-1 10.1056/NEJMoa2019014 10.1016/0014-2999(90)90108-i 10.1113/JP276239 10.14814/phy2.12413 10.1001/jamacardio.2020.1834 10.1038/srep28798 10.1016/j.yjmcc.2011.06.018 10.1016/j.hrthm.2020.05.030 10.1016/j.hrthm.2015.05.027 10.1016/j.taap.2020.115213 10.1161/CIRCEP.120.008662 10.3389/fphar.2021.684252 10.1007/s12012-017-9401-7 10.1021/acsptsci.1c00166 |
ContentType | Journal Article |
Copyright | Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti |
Copyright_xml | – notice: Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. – notice: Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fphar.2023.1127388 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Wu et al |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_b6da9934a8844a17b964cae91e0b70e9 PMC10196358 37214466 10_3389_fphar_2023_1127388 |
Genre | Journal Article |
GrantInformation_xml | – fundername: British Heart Foundation grantid: PG/22/11172 – fundername: NIA NIH HHS grantid: R01 AG049321 – fundername: ; |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c469t-fa61eb2ebca72a17d738ce41cdc30b6561f3a8dc96e5d230efb295ecae89e513 |
IEDL.DBID | M48 |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:32:17 EDT 2025 Thu Aug 21 18:37:00 EDT 2025 Fri Jul 11 12:04:23 EDT 2025 Sat May 31 02:13:32 EDT 2025 Tue Jul 01 02:53:05 EDT 2025 Thu Apr 24 22:51:14 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | COVID-19 cardiotoxicity calcium channels myocardial slices safety pharmacology Bay K8644 organotypic ex-vivo models |
Language | English |
License | Copyright © 2023 Wu, Ross, Ipek, Thompson, Johnson, Wu and Camelliti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c469t-fa61eb2ebca72a17d738ce41cdc30b6561f3a8dc96e5d230efb295ecae89e513 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Daniel M. Johnson, The Open University, United Kingdom Edited by: Jose R. Lopez, Mount Sinai Medical Center, United States Tamer M. A. Mohamed, University of Louisville, United States |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2023.1127388 |
PMID | 37214466 |
PQID | 2818057075 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b6da9934a8844a17b964cae91e0b70e9 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10196358 proquest_miscellaneous_2818057075 pubmed_primary_37214466 crossref_primary_10_3389_fphar_2023_1127388 crossref_citationtrail_10_3389_fphar_2023_1127388 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-05-05 |
PublicationDateYYYYMMDD | 2023-05-05 |
PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2023 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | White (B42) 2007; 7 He (B16) 2019; 10 Saleh (B34) 2020; 13 Chorin (B8) 2020; 26 Tona (B37) 1990; 178 Zhang (B45) 2017; 17 Di Paolo (B12) 2002; 46 Ippolito (B20) 2020; 71 Kang (B23) 2016; 6 Li (B26) 2022; 15 Sanchez-Chapula (B35) 2001; 297 Uzelac (B38) 2020; 17 Wen (B41) 2018; 596 Wong (B43) 2021; 153 Eisner (B13) 2017; 121 Galan (B14) 2017; 23 Wang (B40) 2020; 30 Jiang (B21) 2019; 8 Kim (B25) 2020; 53 Miller (B29) 2020; 406 Himmel (B17) 2012; 166 Perbellini (B32) 2020; 41 Segal (B36) 2022; 13 Yang (B44) 2017; 10 Camelliti (B3) 2011; 51 Chaanine (B6) 2015; 3 Kim (B24) 2021; 24 Ikhinmwin (B19) 1981; 69 Blignaut (B1) 2019; 33 Hughes (B18) 2020; 177 Mamoshina (B27) 2021; 2 Ohara (B31) 2015; 15 Cavalcanti (B5) 2020; 383 Wang (B39) 2021; 4 Riou (B33) 1989; 15 de Boer (B9) 2009; 5 Gielen (B15) 2010; 36 Capel (B4) 2015; 12 Mercuro (B28) 2020; 5 Bussek (B2) 2009; 24 Charrez (B7) 2021; 12 Oguntuyo (B30) 2022; 28 de Olano (B10) 2019; 37 Jordaan (B22) 2021; 180 Delaunois (B11) 2021; 14 |
References_xml | – volume: 28 start-page: 457 year: 2022 ident: B30 article-title: Robust, automated analysis of electrophysiology in induced pluripotent stem cell-derived micro-heart muscle for drug toxicity publication-title: Tissue Eng. Part C Methods doi: 10.1089/ten.tec.2022.0053 – volume: 121 start-page: 181 year: 2017 ident: B13 article-title: Calcium and excitation-contraction coupling in the heart publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.310230 – volume: 15 start-page: 232 year: 2015 ident: B31 article-title: Azithromycin can prolong QT interval and suppress ventricular contraction, but will not induce torsade de Pointes publication-title: Cardiovasc Toxicol. doi: 10.1007/s12012-014-9289-4 – volume: 24 start-page: 103509 year: 2021 ident: B24 article-title: Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells publication-title: iScience doi: 10.1016/j.isci.2021.103509 – volume: 41 start-page: 2405 year: 2020 ident: B32 article-title: Living myocardial slices: A novel multicellular model for cardiac translational research publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehz779 – volume: 26 start-page: 808 year: 2020 ident: B8 article-title: The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin publication-title: Nat. Med. doi: 10.1038/s41591-020-0888-2 – volume: 37 start-page: e5 year: 2019 ident: B10 article-title: Toxicokinetics of hydroxychloroquine following a massive overdose publication-title: Am. J. Emerg. Med. doi: 10.1016/j.ajem.2019.158387 – volume: 30 start-page: 269 year: 2020 ident: B40 article-title: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro publication-title: Cell Res. doi: 10.1038/s41422-020-0282-0 – volume: 71 start-page: 2965 year: 2020 ident: B20 article-title: Dose optimization of hydroxychloroquine for coronavirus infection 2019: Do blood concentrations matter? publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa691 – volume: 8 start-page: 110 year: 2019 ident: B21 article-title: Mitochondrial toxicity of azithromycin results in aerobic glycolysis and DNA damage of human mammary epithelia and fibroblasts publication-title: Antibiot. (Basel) doi: 10.3390/antibiotics8030110 – volume: 24 start-page: 527 year: 2009 ident: B2 article-title: Tissue slices from adult mammalian hearts as a model for pharmacological drug testing publication-title: Cell Physiol. Biochem. doi: 10.1159/000257528 – volume: 180 start-page: 356 year: 2021 ident: B22 article-title: Cardiotoxic potential of hydroxychloroquine, chloroquine and azithromycin in adult human primary cardiomyocytes publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfaa194 – volume: 53 start-page: 545 year: 2020 ident: B25 article-title: Cardiotoxicity induced by the combination therapy of chloroquine and azithromycin in human embryonic stem cell-derived cardiomyocytes publication-title: BMB Rep. doi: 10.5483/BMBRep.2020.53.10.165 – volume: 69 start-page: 507 year: 1981 ident: B19 article-title: The effects of calcium ions on the depression of cardiac contractility by chloroquine and quinine publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(81)90458-1 – volume: 33 start-page: 1 year: 2019 ident: B1 article-title: Revisiting the cardiotoxic effect of chloroquine publication-title: Cardiovasc Drugs Ther. doi: 10.1007/s10557-018-06847-9 – volume: 13 start-page: 839140 year: 2022 ident: B36 article-title: Increase in Ca(2+)-activated cAMP/PKA signaling prevents hydroxychloroquine-induced bradycardia of the cardiac pacemaker publication-title: Front. Physiol. doi: 10.3389/fphys.2022.839140 – volume: 153 start-page: 106 year: 2021 ident: B43 article-title: Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues publication-title: J. Mol. Cell Cardiol. doi: 10.1016/j.yjmcc.2020.12.014 – volume: 46 start-page: 545 year: 2002 ident: B12 article-title: Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily publication-title: Pharmacol. Res. doi: 10.1016/s1043661802002384 – volume: 177 start-page: 4975 year: 2020 ident: B18 article-title: Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam publication-title: Br. J. Pharmacol. doi: 10.1111/bph.15101 – volume: 15 start-page: 220 year: 2022 ident: B26 article-title: Synergistic adverse effects of azithromycin and hydroxychloroquine on human cardiomyocytes at a clinically relevant treatment duration publication-title: Pharm. (Basel) doi: 10.3390/ph15020220 – volume: 297 start-page: 437 year: 2001 ident: B35 article-title: Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes publication-title: J. Pharmacol. Exp. Ther. – volume: 2 start-page: 100216 year: 2021 ident: B27 article-title: Toward a broader view of mechanisms of drug cardiotoxicity publication-title: Cell Rep. Med. doi: 10.1016/j.xcrm.2021.100216 – volume: 10 start-page: e003560 year: 2017 ident: B44 article-title: Azithromycin causes a novel proarrhythmic syndrome publication-title: Circ. Arrhythm. Electrophysiol. doi: 10.1161/CIRCEP.115.003560 – volume: 5 start-page: 425 year: 2009 ident: B9 article-title: Myocardial tissue slices: Organotypic pseudo-2D models for cardiac research & development publication-title: Future Cardiol. doi: 10.2217/fca.09.32 – volume: 23 year: 2017 ident: B14 article-title: Negative inotropic action and QT prolongation by azithromycin publication-title: Rev. Cuba. Cardiol. Cir. Cardiovasc. – volume: 10 start-page: 755 year: 2019 ident: B16 article-title: A protocol for transverse cardiac slicing and optical mapping in murine heart publication-title: Front. Physiol. doi: 10.3389/fphys.2019.00755 – volume: 15 start-page: 390 year: 1989 ident: B33 article-title: Diazepam does not improve the mechanical performance of rat cardiac papillary muscle exposed to chloroquine in vitro publication-title: Intensive Care Med. doi: 10.1007/BF00261499 – volume: 166 start-page: 276 year: 2012 ident: B17 article-title: Field and action potential recordings in heart slices: Correlation with established in vitro and in vivo models publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2011.01775.x – volume: 14 start-page: 1133 year: 2021 ident: B11 article-title: Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off-label in the first wave of COVID-19 publication-title: Clin. Transl. Sci. doi: 10.1111/cts.13011 – volume: 36 start-page: 646 year: 2010 ident: B15 article-title: Azithromycin induces anti-viral responses in bronchial epithelial cells publication-title: Eur. Respir. J. doi: 10.1183/09031936.00095809 – volume: 7 start-page: 549 year: 2007 ident: B42 article-title: Cardiotoxicity of antimalarial drugs publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(07)70187-1 – volume: 383 start-page: 2041 year: 2020 ident: B5 article-title: Hydroxychloroquine with or without azithromycin in mild-to-moderate covid-19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2019014 – volume: 178 start-page: 293 year: 1990 ident: B37 article-title: Depressant effects of chloroquine on the isolated Guinea-pig heart publication-title: Eur. J. Pharmacol. doi: 10.1016/0014-2999(90)90108-i – volume: 596 start-page: 3951 year: 2018 ident: B41 article-title: Transverse cardiac slicing and optical imaging for analysis of transmural gradients in membrane potential and Ca(2+) transients in murine heart publication-title: J. Physiol. doi: 10.1113/JP276239 – volume: 3 start-page: e12413 year: 2015 ident: B6 article-title: High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy publication-title: Physiol. Rep. doi: 10.14814/phy2.12413 – volume: 5 start-page: 1036 year: 2020 ident: B28 article-title: Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19) publication-title: JAMA Cardiol. doi: 10.1001/jamacardio.2020.1834 – volume: 6 start-page: 28798 year: 2016 ident: B23 article-title: Human organotypic cultured cardiac slices: New platform for high throughput preclinical human trials publication-title: Sci. Rep. doi: 10.1038/srep28798 – volume: 51 start-page: 390 year: 2011 ident: B3 article-title: Adult human heart slices are a multicellular system suitable for electrophysiological and pharmacological studies publication-title: J. Mol. Cell Cardiol. doi: 10.1016/j.yjmcc.2011.06.018 – volume: 17 start-page: 1445 year: 2020 ident: B38 article-title: Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19 publication-title: Heart rhythm. doi: 10.1016/j.hrthm.2020.05.030 – volume: 12 start-page: 2186 year: 2015 ident: B4 article-title: Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential publication-title: Heart rhythm. doi: 10.1016/j.hrthm.2015.05.027 – volume: 406 start-page: 115213 year: 2020 ident: B29 article-title: Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity publication-title: Toxicol. Appl. Pharmacol. doi: 10.1016/j.taap.2020.115213 – volume: 13 start-page: e008662 year: 2020 ident: B34 article-title: Effect of chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection publication-title: Circ. Arrhythm. Electrophysiol. doi: 10.1161/CIRCEP.120.008662 – volume: 12 start-page: 684252 year: 2021 ident: B7 article-title: Heart muscle microphysiological system for cardiac liability prediction of repurposed COVID-19 therapeutics publication-title: Front. Pharmacol. doi: 10.3389/fphar.2021.684252 – volume: 17 start-page: 434 year: 2017 ident: B45 article-title: Electrophysiologic studies on the risks and potential mechanism underlying the proarrhythmic nature of azithromycin publication-title: Cardiovasc Toxicol. doi: 10.1007/s12012-017-9401-7 – volume: 4 start-page: 1639 year: 2021 ident: B39 article-title: Electrophysiological and proarrhythmic effects of hydroxychloroquine challenge in Guinea-pig hearts publication-title: ACS Pharmacol. Transl. Sci. doi: 10.1021/acsptsci.1c00166 |
SSID | ssj0000399364 |
Score | 2.3193207 |
Snippet | The cardiotoxicity risk of hydroxychloroquine (HCQ) and azithromycin (AZM) has been the subject of intensive research triggered by safety concerns in COVID-19... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1127388 |
SubjectTerms | calcium channels cardiotoxicity COVID-19 myocardial slices organotypic ex-vivo models Pharmacology safety pharmacology |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iyYv4tr6IIHvR4qZJ0_aooiyC4mEF8RLyKrug3UXXw_rrnUm7LxG9eO2Dhplp5_uamW8IOZGFTTgwthgTQiwM97FuGxa7xPnSccONRaJ4dy87j-L2KX2aG_WFNWG1PHBtuHMjnYYcKnSeC6FZZgoprPYF822TtX1o3YOcN0emwjcY864UdZcMsLDivBz2NOp_Jhy7ZjIeRq3MMlEQ7P8JZX4vlpzLPjdrZLWBjfSiXu46WfLVBmk91LrT4zPanbVRvZ_RFn2YKVKPN8lzZ-ywXMX2gJ3DkwFZUl05qj_7OCbhdWz7FQ375hTwIA3l69jwgBCdDkr60sffDhSgOm7DUxyCPaIAUOEbs0W6N9fdq07cDFWILTDhUVxqycA3WAOVJWBPB6awXjDrLG8bQHes5Dp3tpA-dcBPfGmSIvVg8rzwKePbZLkaVH6X0EQDXNBG6Exq4fO0KNNEll5Kxy2QOBMRNrGvso3gOM69eFFAPNAnKvhEoU9U45OInE7vGdZyG79efYlum16JUtnhAASQagJI_RVAETmeOF3Bq4X7Jbryg493hUJZAGcBVEVkpw6C6aN4FrTmZETyhfBYWMvimarfC_LdDCWJeJrv_cfq98kKWiSUYKYHZHn09uEPASaNzFF4I74AtOAVHw priority: 102 providerName: Directory of Open Access Journals |
Title | Hydroxychloroquine and azithromycin alter the contractility of living porcine heart slices |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37214466 https://www.proquest.com/docview/2818057075 https://pubmed.ncbi.nlm.nih.gov/PMC10196358 https://doaj.org/article/b6da9934a8844a17b964cae91e0b70e9 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcuGCeBP6kJFQLzSwjh3HOVQIENUKqaiHrVRxifxKd6UlW3a3UtNfz4yT3bKocOCa2EoyY3u-Lx5_A_BGlS4TyNhSCgiptCKkZmB56jMfai-ssI6I4sk3NTyTX8_z8y1YlTvqDbi4k9pRPamz-fTd9c_2A074I2KcGG_f15djQ9KemaADMYXQ-h7cx8hUUEWDkx7ux5WZorGS3dmZv3TdiE9Rxv8u7PlnCuVvMen4ETzswST72Hn_MWyF5gkcnHZq1O0hG90erlocsgN2eqtT3T6F78PWUxKLGyNnxycj3mSm8czcTKh4wo_WTRoWd9MZokQWk9rpGAQBdzar2XRCPyMY2o425xmVxl4yhK248jyD0fGX0edh2pdaSB3y42VaG8XRY5QZVWSGFx5N4YLkzjsxsIj5eC2M9q5UIffIWkJtszIPzgRdhpyL57DdzJrwElhmEEQYK02hjAw6L-s8U3VQyguH1M4mwFf2rVwvQ07VMKYV0hHySRV9UpFPqt4nCbxd97nsRDj-2foTuW3dkgS044XZ_KLq52NllTc4GKTRWkr8YFsqiV9T8jCwxSCUCbxeOb3CCUe7KKYJs6tFRfJZCHIRaiXwohsE60eJIirQqQT0xvDYeJfNO81kHEW9OQkViVy_-v-uO_CA7BDTMfNd2F7Or8IeQqal3Y-_GvbjbPgFz34dRw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hydroxychloroquine+and+azithromycin+alter+the+contractility+of+living+porcine+heart+slices&rft.jtitle=Frontiers+in+pharmacology&rft.au=Wu%2C+Qin&rft.au=Ross%2C+Abigail+J.&rft.au=Ipek%2C+Tugce&rft.au=Thompson%2C+Georgina+H.&rft.date=2023-05-05&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=14&rft_id=info:doi/10.3389%2Ffphar.2023.1127388&rft.externalDocID=PMC10196358 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |